1) BOT received a CRL - it indicated the only negatives related to NON-clinical matters - meaning, IF they have all been adequately addressed, the drug should be approved - the FDA flagged NO drug related issues in the CRL.
2) All royalties are now owned by BOT - except a master 5% royalty to the lab that first developed the drug candidate - BOT bought out all the previous commercial promoters royalties - ie, all royalties now 95% owned by BOT! A VERY Wise move!!!!
I hope BOT approval drops in the next few weeks....it should be a bit early...but that's just wild speculation on my part....but given it's all packaging/labelling/diagram issues.....fingers crossed!
- Forums
- ASX - By Stock
- Sofdra - Post approval royalties, costs and earnings
1) BOT received a CRL - it indicated the only negatives related...
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $441.0M |
Open | High | Low | Value | Volume |
28.0¢ | 29.0¢ | 27.5¢ | $1.247M | 4.402M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 684251 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 210000 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 684251 | 0.280 |
16 | 916601 | 0.275 |
11 | 1364437 | 0.270 |
12 | 538050 | 0.265 |
18 | 521601 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 210000 | 8 |
0.290 | 525169 | 16 |
0.295 | 563313 | 7 |
0.300 | 980356 | 15 |
0.305 | 180200 | 4 |
Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
Last
28.3¢ |
  |
Change
0.005 ( 3.10 %) |
|||
Open | High | Low | Volume | ||
27.5¢ | 29.0¢ | 27.5¢ | 1730488 | ||
Last updated 15.58pm 13/05/2024 ? |
Featured News
BOT (ASX) Chart |
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
SPONSORED BY The Market Online